CD4+TCRαβ+ T-cells developing after allogeneic bone marrow transplantation in patients with chronic myelogenous leukaemia. Dipyridamole inhibits functionally heterogeneous T-cell clones

This publication has 14 references indexed in Scilit:

• The additive effect of certain drugs on the Cyclosporine A inhibition of human T‐cell proliferation
  APMIS, 1990
• Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-α-treated chronic myelogenous leukaemia patients
  Cancer Immunology, Immunotherapy, 1990
• Studies of the proliferation and differentiation of immature myeloid cells in vitro. I. chronic myelogenous leukemia
  American Journal of Hematology, 1989
• Differential secretion of tumor necrosis factor-α and granulocyte/macrophage colony-stimulating factors but not interferon-γ from CD4 compared to CD8 human T cell clones
  European Journal of Immunology, 1989
• Dipyridamol inhibits activation of human T lymphocytes in vitro
  Clinical Immunology and Immunopathology, 1987
• Effect of dipyridamole upon thymidine incorporation and capping in human lymphocytes
  International Journal of Immunopharmacology, 1986
• PERCOLL SEPARATION OF LEUKEMIC LEUKOCYTES FOR MLC MATCHING PRIOR TO BONE MARROW TRANSPLANTATION
  Transplantation, 1985
• Clinical pharmacokinetics of dipyridamole
  Thrombosis Research, 1983
• Allogeneically primed T lymphocyte clones in the analysis of lymphocyte stimulatory determinants
  Human Immunology, 1983
• Effects of dipyridamole on human blood lymphocytes
  Biochemical Pharmacology, 1980